Eric Boodman, a STAT general assignment reporter, is the author of a series about sickle cell disease and forced sterilizations. She knew what it was to have pain she couldn’t put into words ...
Pfizer PFE0.78%increase; green up pointing triangle said it is voluntarily withdrawing all lots of its sickle-cell drug Oxbryta in all markets where it is approved, two years after acquiring its ...
Titled "Building with Living Trees", this first instalment highlights the stories behind Casa Jardín (Garden House), a single-family home located in the suburban area of Quito, Ecuador.
LOS ANGELES, Sept 28 (Reuters) - Student Zoe Davis, 20, was just weeks into her junior year when she landed back in the hospital with severe sickle cell pain earlier this month. She is doing what ...
But not everyone has the space for a large outdoor garden. If you live in an apartment or lack usable yard space, you can still create your dream garden indoors -- just start with plant pods.
Pfizer said Wednesday that it was removing Oxbryta, a pill for the treatment of sickle cell disease, from all markets globally due to high risks of severe safety events, including deaths.
The EU's drug watchdog Thursday called for the suspension of approval for Pfizer's medicine to treat sickle cell disease, saying doctors should stop using the drug. The European Medicines Agency's ...
Sept 26 (Reuters) - U.S. drugmaker Pfizer (PFE.N), opens new tab said on Wednesday it was withdrawing its sickle cell disease treatment Oxbryta from all markets where it is approved, citing risks ...
(NYSE: PFE) announced today that it is voluntarily withdrawing all lots of OXBRYTA ® (voxelotor) for the treatment of sickle cell disease (SCD) at this time, in all markets where it is approved.
Beata Zawrzel / NurPhoto via Getty Images Pfizer is withdrawing all of its sickle cell disease drug, Oxbryta, worldwide because of safety concerns. The drug maker said the benefits of Oxbryta no ...
Pfizer (NYSE:PFE) has voluntarily withdrawn all lots of its sickle cell disease drug Oxbryta, also known as voxelotor, over safety concerns. The pharmaceutical giant said Oxbryta will be withdrawn ...
A new hike through the rice paddies and forested interior of Bali offers a meaningful way to experience Indonesia’s ‘Island ...